Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects

Oncotarget. 2021 Dec 7;12(25):2476-2488. doi: 10.18632/oncotarget.28088.

Abstract

A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus producing syncytia found in COVID-19 patients. This commentary proposes how this ability enables spike to cause COVID-19 complications as well as side effects of COVID-19 vaccines, and suggests how these effects can be prevented.

Keywords: cancer; cell fusion; neuropathy; thrombosis; vaccines.